|
|
||||||||

*
Department of Pathology, University of Western Australia, Queen Elizabeth II Medical Center, Nedlands, Western Australia, Australia;
Trescowthick Research Laboratories, Peter MacCallum Cancer Institute, Melbourne, Victoria, Australia
Recent studies indicate that c-Cbl and its oncogenic variants can
modulate the activity of protein tyrosine kinases. This finding is
supported by studies showing that c-Cbl interacts directly with a
negative regulatory tyrosine in ZAP-70, and that the levels of
tyrosine-phosphorylated ZAP-70 and numerous other proteins are
increased in TCR-stimulated thymocytes from c-Cbl-deficient mice. Here,
we demonstrate that this enhanced phosphorylation of ZAP-70 and that of
two substrates, LAT and SLP-76, is not due to altered protein levels
but is the consequence of two separate events. First, we find increased
expression of tyrosine-phosphorylated TCR
chain in c-Cbl-deficient
thymocytes, which results in a higher level of
-chain-associated
ZAP-70 that is initially accessible for activation. Thus, more ZAP-70
is activated and more of its substrates (LAT and SLP-76) become
tyrosine-phosphorylated after TCR stimulation. However, an additional
mechanism of ZAP-70 regulation is evident at a later time
poststimulation. At this time, ZAP-70 from both normal and
c-Cbl-/- thymocytes becomes hyperphosphorylated; however,
only in normal thymocytes does this correlate with ZAP-70
down-regulation and a diminished ability to phosphorylate LAT and
SLP-76. In contrast, c-Cbl-deficient thymocytes display altered
phosphorylation kinetics, for which LAT phosphorylation is increased
and SLP-76 phosphorylation is sustained. Thus, the ability to
down-regulate the phosphorylation of two ZAP-70 substrates is impaired
in c-Cbl-/- thymocytes. These findings provide evidence
that c-Cbl is involved in the negative regulation of the
phosphorylation of LAT and SLP-76 by ZAP-70.
This article has been cited by other articles:
![]() |
L. Balagopalan, V. A. Barr, C. L. Sommers, M. Barda-Saad, A. Goyal, M. S. Isakowitz, and L. E. Samelson c-Cbl-Mediated Regulation of LAT-Nucleated Signaling Complexes Mol. Cell. Biol., December 15, 2007; 27(24): 8622 - 8636. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Gustin, C. B. F. Thien, and W. Y. Langdon Cbl-b Is a Negative Regulator of Inflammatory Cytokines Produced by IgE-Activated Mast Cells J. Immunol., November 1, 2006; 177(9): 5980 - 5989. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zhang, Y. J. Chiang, R. J. Hodes, and R. P. Siraganian Inactivation of c-Cbl or Cbl-b Differentially Affects Signaling from the High Affinity IgE Receptor J. Immunol., August 1, 2004; 173(3): 1811 - 1818. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. J. Chiang, C. L. Sommers, M. S. Jordan, H. Gu, L. E. Samelson, G. A. Koretzky, and R. J. Hodes Inactivation of c-Cbl Reverses Neonatal Lethality and T Cell Developmental Arrest of SLP-76-deficient Mice J. Exp. Med., July 6, 2004; 200(1): 25 - 34. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. F. Hoyne Notch signaling in the immune system J. Leukoc. Biol., December 1, 2003; 74(6): 971 - 981. [Abstract] [Full Text] |
||||
![]() |
C. B.F. Thien, R. M. Scaife, J. M. Papadimitriou, M. A. Murphy, D. D.L. Bowtell, and W. Y. Langdon A Mouse with a Loss-of-function Mutation in the c-Cbl TKB Domain Shows Perturbed Thymocyte Signaling without Enhancing the Activity of the ZAP-70 Tyrosine Kinase J. Exp. Med., February 17, 2003; 197(4): 503 - 513. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Dumont, N. Blanchard, V. Di Bartolo, N. Lezot, E. Dufour, S. Jauliac, and C. Hivroz TCR/CD3 Down-Modulation and {zeta} Degradation Are Regulated by ZAP-70 J. Immunol., August 15, 2002; 169(4): 1705 - 1712. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yasuda, T. Tezuka, A. Maeda, T. Inazu, Y. Yamanashi, H. Gu, T. Kurosaki, and T. Yamamoto Cbl-b Positively Regulates Btk-mediated Activation of Phospholipase C-{gamma}2 in B Cells J. Exp. Med., July 1, 2002; 196(1): 51 - 63. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Loreto, D. M. Berry, and C. J. McGlade Functional Cooperation between c-Cbl and Src-Like Adaptor Protein 2 in the Negative Regulation of T-Cell Receptor Signaling Mol. Cell. Biol., June 15, 2002; 22(12): 4241 - 4255. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Rao, I. Dodge, and H. Band The Cbl family of ubiquitin ligases: critical negative regulators of tyrosine kinase signaling in the immune system J. Leukoc. Biol., May 1, 2002; 71(5): 753 - 763. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Freywald, N. Sharfe, and C. M. Roifman The Kinase-null EphB6 Receptor Undergoes Transphosphorylation in a Complex with EphB1 J. Biol. Chem., February 1, 2002; 277(6): 3823 - 3828. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Magnan, V. Di Bartolo, A.-M. Mura, C. Boyer, M. Richelme, Y.-L. Lin, A. Roure, A. Gillet, C. Arrieumerlou, O. Acuto, et al. T Cell Development and T Cell Responses in Mice with Mutations Affecting Tyrosines 292 or 315 of the ZAP-70 Protein Tyrosine Kinase J. Exp. Med., August 20, 2001; 194(4): 491 - 506. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. de Melker, G. van der Horst, J. Calafat, H. Jansen, and J. Borst c-Cbl ubiquitinates the EGF receptor at the plasma membrane and remains receptor associated throughout the endocytic route J. Cell Sci., January 6, 2001; 114(11): 2167 - 2178. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yi, M. McNerney, and S. K. Datta Regulatory Defects in Cbl and Mitogen-Activated Protein Kinase (Extracellular Signal-Related Kinase) Pathways Cause Persistent Hyperexpression of CD40 Ligand in Human Lupus T Cells J. Immunol., December 1, 2000; 165(11): 6627 - 6634. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Rao, M. L. Lupher Jr., S. Ota, K. A. Reedquist, B. J. Druker, and H. Band The Linker Phosphorylation Site Tyr292 Mediates the Negative Regulatory Effect of Cbl on ZAP-70 in T Cells J. Immunol., May 1, 2000; 164(9): 4616 - 4626. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Peters, M. Tsuchida, E. R. Manthei, T. Alam, C. S. Cho, S. J. Knechtle, and M. M. Hamawy Potentiation of CD3-induced expression of the linker for activation of T cells (LAT) by the calcineurin inhibitors cyclosporin A and FK506 Blood, May 1, 2000; 95(9): 2733 - 2741. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Utting, S.-J. Teh, and H.-S. Teh A Population of In Vivo Anergized T Cells with a Lower Activation Threshold for the Induction of CD25 Exhibit Differential Requirements in Mobilization of Intracellular Calcium and Mitogen-Activated Protein Kinase Activation J. Immunol., March 15, 2000; 164(6): 2881 - 2889. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yasuda, A. Maeda, M. Kurosaki, T. Tezuka, K. Hironaka, T. Yamamoto, and T. Kurosaki Cbl Suppresses B Cell Receptor-mediated Phospholipase C (PLC)-{gamma}2 Activation by Regulating B Cell Linker Protein-PLC-{gamma}2 Binding J. Exp. Med., February 21, 2000; 191(4): 641 - 650. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Scaife and W. Langdon c-Cbl localizes to actin lamellae and regulates lamellipodia formation and cell morphology J. Cell Sci., January 1, 2000; 113(2): 215 - 226. [Abstract] [PDF] |
||||
![]() |
G. Pedraza-Alva, S. Sawasdikosol, Y. C. Liu, L. B. Merida, M. E. Cruz-Munoz, F. Oceguera-Yanez, S. J. Burakoff, and Y. Rosenstein Regulation of Cbl Molecular Interactions by the Co-receptor Molecule CD43 in Human T Cells J. Biol. Chem., January 5, 2001; 276(1): 729 - 737. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |